메뉴 건너뛰기




Volumn 879, Issue 19, 2011, Pages 1573-1586

Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay

Author keywords

Bridion; Dialysate; Liquid chromatography tandem mass spectrometry (LC MS MS); Plasma; Sugammadex; Urine

Indexed keywords

BRIDION; DIALYSATE; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC-MS/MS); SUGAMMADEX; URINE;

EID: 79955886020     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.03.050     Document Type: Article
Times cited : (20)

References (21)
  • 10
    • 84856069632 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Bioanalytical Method Validation. May Available from: (accessed 20.07.10).
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Bioanalytical Method Validation. May 2001. Available from: (accessed 20.07.10). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.